Prognosis: Breakthrough

This Drug Maker Saw the Pandemic Coming

Prognosis: Breakthrough

When Covid-19 hit, Gilead Sciences Inc. had enough of its experimental drug remdesivir ready to test and start manufacturing it at a larger scale. That's because it had started stockpiling not just the drug, but its ingredients, at the first hint there may be a new coronavirus. Robert Langreth reports on why the company was able to act early to prepare for a pandemic when so many businesses and institutions did not. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Next Episodes

Prognosis: Breakthrough

The Scary Implications of 'Covid Toe' @ Prognosis: Breakthrough

📆 2020-05-13 22:31 / 00:13:52


Prognosis: Breakthrough

Your Quarantine Questions, Answered @ Prognosis: Breakthrough

📆 2020-05-12 22:28 / 00:18:35


Prognosis: Breakthrough

New Fears About Kids Getting Sick @ Prognosis: Breakthrough

📆 2020-05-11 23:09 / 00:16:38


Prognosis: Breakthrough

Is the Virus Getting Worse? @ Prognosis: Breakthrough

📆 2020-05-08 23:00 / 00:15:06


Prognosis: Breakthrough

The Problem With Antibody Tests @ Prognosis: Breakthrough

📆 2020-05-07 22:43 / 00:13:40